Therapeutic Strategies for Patients with Advanced Small Bowel Adenocarcinoma: Current Knowledge and Perspectives by Emilie Moati, Michael J. Overman, Aziz Zaanan

Get full text

Molecular Landscape of Small Bowel Adenocarcinoma by Karan Pandya, Michael J. Overman, Pat Gulhati

Get full text

Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy by Preeti Kanikarla-Marie, Michael Lam, Alexey V. Sorokin, Michael J. Overman, Scott Kopetz, David G. Menter

Get full text

Underreporting of race/ethnicity in COVID-19 research by Kanwal Raghav, Seerat Anand, Anirudh Gothwal, Pooja Singh, Arvind Dasari, Michael J. Overman, Jonathan M. Loree

Get full text

Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes. by Kanwal Raghav, Hemendra Mhadgut, Jennifer L McQuade, Xiudong Lei, Alicia Ross, Aurelio Matamoros, Huamin Wang, Michael J Overman, Gauri R Varadhachary

Get full text

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma by Reham Abdel-Wahab, Gauri R. Varadhachary, Priya R. Bhosale, Xuemei Wang, David R. Fogelman, Rachna T. Shroff, Michael J. Overman, Robert A. Wolff, Milind Javle

Get full text

The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer. by Christopher H Lieu, Hai Tran, Zhi-Qin Jiang, Muling Mao, Michael J Overman, E Lin, Cathy Eng, Jeffrey Morris, Lee Ellis, John V Heymach, Scott Kopetz

Get full text

Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer by Chiara Cremolini, Francesca Corti, Elisabetta Fenocchio, Michael J Overman, Lisa Salvatore, Rossana Intini, Priya Jayachandran, Javier Ros, Maria Elena Elez, Aakash Tushar Shah, Rosalba Miceli, Monica Niger, Giacomo Mazzoli, Francesco Barretta

Get full text

Comprehensive Landscape of BRAF Variant Classes, Clonalities, and Co-Mutations in Metastatic Colorectal Cancer Using ctDNA Profiling by Benny Johnson, Van Morris, Xuemei Wang, Arvind Dasari, Kanwal Raghav, John Paul Shen, Michael S. Lee, Ryan Huey, Christine Parseghian, Jason Willis, Robert Wolff, Leylah M. Drusbosky, Michael J. Overman, Scott Kopetz

Get full text

Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts by Preeti Kanikarla Marie, Alexey V. Sorokin, Lea A. Bitner, Rebecca Aden, Michael Lam, Ganiraju Manyam, Melanie N. Woods, Amanda Anderson, Anna Capasso, Natalie Fowlkes, Michael J. Overman, David G. Menter, Scott Kopetz

Get full text

An analysis of research biopsy core variability from over 5000 prospectively collected core samples by Deepak Bhamidipati, Anuj Verma, Dawen Sui, Dipen Maru, Grace Mathew, Wenhua Lang, Juan Posadas, Joshua Hein, Scott Kopetz, Andrew Futreal, Ignacio I. Wistuba, Sanjay Gupta, J. Jack Lee, Michael J. Overman, Alda L. Tam

Get full text

Correction: Gene Expression Profiling of Ampullary Carcinomas Classifies Ampullary Carcinomas into Biliary-Like and Intestinal-Like Subtypes That Are Prognostic of Outcome. by Michael J. Overman, Jiexin Zhang, Scott Kopetz, Michael Davies, Zhi-Qin Jiang, Katherine Stemke-Hale, Petra Rümmele, Christian Pilarsky, Robert Grützmann, Stanley Hamilton, Rosa Hwang, James L. Abbruzzese, Gauri Varadhachary, Bradley Broom, Huamin Wang

Get full text

Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome. by Michael J Overman, Jiexin Zhang, Scott Kopetz, Michael Davies, Zhi-Qin Jiang, Katherine Stemke-Hale, Petra Rümmele, Christian Pilarsky, Robert Grützmann, Stanley Hamilton, Rosa Hwang, James L Abbruzzese, Gauri Varadhachary, Bradley Broom, Huamin Wang

Get full text

The Provocative Roles of Platelets in Liver Disease and Cancer by Preeti Kanikarla Marie, Natalie W. Fowlkes, Vahid Afshar-Kharghan, Stephanie L. Martch, Alexey Sorokin, John Paul Shen, Van K. Morris, Arvind Dasari, Nancy You, Anil K. Sood, Michael J. Overman, Scott Kopetz, David George Menter

Get full text

Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer. by Amir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, Ganiraju Manyam, Bryan K Kee, David R Fogelman, Arvind Dasari, Kanwal Raghav, Eduardo Vilar, Shanequa Manuel, Imad Shureiqi, Robert A Wolff, Keyur P Patel, Raja Luthra, Kenna Shaw, Cathy Eng, Dipen M Maru, Mark J Routbort, Funda Meric-Bernstam, Scott Kopetz

Get full text

Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients by Chirayu Mohindroo, Merve Hasanov, Jane E. Rogers, Wenli Dong, Laura R. Prakash, Seyda Baydogan, Jonathan D. Mizrahi, Michael J. Overman, Gauri R. Varadhachary, Robert A. Wolff, Milind M. Javle, David R. Fogelman, Michael T. Lotze, Michael P. Kim, Matthew H.G. Katz, Shubham Pant, Ching‐Wei D. Tzeng, Florencia McAllister

Get full text

Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma by Patrick Hwu, Chantale Bernatchez, Shubham Pant, Marie-Andree Forget, Milind Javle, Donastas Sakellariou-Thompson, Karen H Lu, Scott Kopetz, Mara B Antonoff, Cara L Haymaker, Ying Yuan, Robert A Wolff, Michael J Overman, Anne Knisely, Amir A Jazaeri, Bryan Fellman, Kelly Rangel, David Vining, Ching-Wei D Tzeng, Kathryn Lito

Get full text

Survival improvement for patients with metastatic colorectal cancer over twenty years by Fadl A. Zeineddine, Mohammad A. Zeineddine, Abdelrahman Yousef, Yue Gu, Saikat Chowdhury, Arvind Dasari, Ryan W. Huey, Benny Johnson, Bryan Kee, Michael S. Lee, Maria Pia Morelli, Van K. Morris, Michael J. Overman, Christine Parseghian, Kanwal Raghav, Jason Willis, Robert A. Wolff, Yoshikuni Kawaguchi, Jean-Nicolas Vauthey, Ryan Sun, Scott Kopetz, John Paul Shen

Get full text

Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC) by Ignacio I Wistuba, Andrew Futreal, Xuemei Wang, Arvind Dasari, Cathy Eng, Scott Kopetz, Edwin R Parra, Cara L Haymaker, Eduardo Vilar, Robert A Wolff, Kanwal Raghav, Michael J Overman, Younghee Lee, Benny Johnson, Luisa Maren Solis Soto, Jane V Thomas, Van K Morris, Bryan K Kee, Christine M Parseghian, Daniele Lorenzini, Caddie Laberiano-Fernandez, Anuj Verma, Wenhua Lang

Get full text

Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation by Marie-Claude Gingras, Kyle R. Covington, David K. Chang, Lawrence A. Donehower, Anthony J. Gill, Michael M. Ittmann, Chad J. Creighton, Amber L. Johns, Eve Shinbrot, Ninad Dewal, William E. Fisher, Christian Pilarsky, Robert Grützmann, Michael J. Overman, Nigel B. Jamieson, George Van Buren II, Jennifer Drummond, Kimberly Walker, Oliver A. Hampton, Liu Xi, Donna M. Muzny, Harsha Doddapaneni, Sandra L. Lee, Michelle Bellair, Jianhong Hu, Yi Han, Huyen H. Dinh, Mike Dahdouli, Jaswinder S. Samra, Peter Bailey, Nicola Waddell, John V. Pearson, Ivon Harliwong, Huamin Wang, Daniela Aust, Karin A. Oien, Ralph H. Hruban, Sally E. Hodges, Amy McElhany, Charupong Saengboonmee, Fraser R. Duthie, Sean M. Grimmond, Andrew V. Biankin, David A. Wheeler, Richard A. Gibbs

Get full text